サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1738023

慢性完全閉塞（CTO）の世界市場 - 市場規模と予測（2021年～2031年）、世界・地域シェア、動向、成長機会分析：機器別、エンドユーザー別、地域別

Chronic Total Occlusion Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Equipment, End User, and Geography

出版日
ページ情報
英文 196 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.76円
慢性完全閉塞（CTO）の世界市場 - 市場規模と予測（2021年～2031年）、世界・地域シェア、動向、成長機会分析：機器別、エンドユーザー別、地域別
出版日: 2025年04月29日
発行: The Insight Partners
ページ情報: 英文 196 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

弊社の最新調査レポートによると、慢性完全閉塞（CTO）の世界市場は2024年の24億4,000万米ドルから成長し、2031年には42億2,000万米ドルに達し、2025年から2031年のCAGRで8.2％の成長が予測されています。高齢化人口の増加と心血管疾患の有病率の上昇が慢性完全閉塞（CTO）市場規模の拡大に寄与しています。しかし、閉塞装置のコストが高いことが慢性完全閉塞（CTO）市場の成長を阻害しています。さらに、CTOデバイスの技術的進歩が、今後数年間で慢性完全閉塞（CTO）市場に新たな動向をもたらすと期待されています。

収益面では、北米が2024年の市場を独占しました。予測期間中も世界市場を独占すると推定されます。米国は世界最大の慢性完全閉塞（CTO）市場です。

米国の慢性完全閉塞（CTO）市場は、高齢化に伴うCVD、特に冠動脈疾患（CAD）の罹患率の上昇に伴って拡大しています。Division of Occupational Employment and Wage Statisticsによると、2023年時点で米国で雇用されている循環器専門医は1万5,190人です。さらに、心血管系の健康に対する意識の高まりとCTOの早期発見が、これらの介入に対する需要を煽っています。

慢性完全閉塞（CTO）市場分析

将来の市場機会を提供する市場プレイヤーの戦略的取り組み

CTO市場で事業を展開する企業は、製品承認、提携、資金調達、契約、新製品発売などの戦略的開拓に絶えず注力しており、これらの戦略的開拓は、売上の向上、地理的リーチの拡大、既存顧客ベース以上の顧客層に対応するための能力強化に役立っています。CTO市場で事業を展開する主要企業による戦略的イニシアチブを以下にいくつか紹介します。

2022年2月、Teleflex Incorporatedは、米国食品医薬品局（FDA）が同社の特殊カテーテルと冠動脈ガイドワイヤーについて、特に慢性完全閉塞（CTO）経皮的冠動脈インターベンション（CTO PCI）での使用に適応拡大を認めたと発表しました。

2024年6月、MicroPort RotaPaceの血管内ピエゾ式ガイドワイヤシステムは、革新的医療機器に対する特別審査手続きへの参加についてNMPAの承認を得た。このシステムは復旦大学中山病院の葛淳甫学長が率いるチームによって共同開発されました。

2024年2月、BIOTRONIKはMicro Rxカテーテルを発表しました。Micro Rxカテーテルは、PCI時のガイドワイヤー支持を容易に強化するために開発された、新しい高速交換マイクロカテーテルです。Micro RxカテーテルはBIOTRONIKが米国市場に投入した4番目のIMDS製品であり、NHancer Rx、TrapIT、ReCrossカテーテルを含む強力な機器ポートフォリオに貢献しています。

2022年10月、FDA承認のマイクロカテーテルNovaCrossラインは、Microbot Medical Inc.がNitiloop Ltd.から購入した資産の一つです。NovaCrossデバイスは、経皮経管冠動脈形成術やステントインターベンションの前に、慢性完全閉塞（CTO）を含む狭窄病変の先に従来型ガイドワイヤーやステアラブルガイドワイヤーを容易に留置できるように設計されています。

2022年4月、FDAはTransit ScientificのXOクロスサポートカテーテルプラットフォームを冠動脈用として承認しました。このプラットフォームは、末梢動脈や冠動脈へのアクセス時に、ワイヤーの交換を容易にし、ガイドワイヤーを誘導・維持し、診断用造影剤や生理食塩水を投与するための導管として機能することを目的としています。

2022年2月、FDAはTeleflex Incorporatedの専用カテーテルと冠動脈ガイドワイヤーについて、経皮的冠動脈インターベンション（PCI）の際に慢性完全閉塞（CTO）を横断する際に使用する適応症を追加承認しました。

2023年9月、Avinger, Inc.は次世代画像ガイド下CTO横断システムTigereye STの本格的な商業開始を発表しました。本格的な商業販売の開始により、現在Tigereye STデバイスを注文している顧客および今後注文を予定している顧客はすべてTigereye STデバイスを注文できるようになります。

したがって、製品の上市、承認、提携により、今後数年間は慢性完全閉塞（CTO）市場の成長に十分な機会が創出されると期待されます。

慢性完全閉塞（CTO）市場：競合情勢と主な発展

Asahi Intecc Co Ltd、Cordis Corp、Integer Holdings Corp、Boston Scientific Corp、Becton Dickinson and Co、SoundBite Medical Solutions、Medtronic Plc、Terumo Corp、Abbott、Koninklijke Philips NVなどが慢性完全閉塞（CTO）市場で事業を展開する主要企業です。

米国国勢調査局、世界保健機関（WHO）、英国心臓財団、フランス国立人口統計研究所、国立統計研究所（NIS）、国立医学図書館、国立犯罪記録局（NCRB）、国立生物工学情報センターなどは、慢性完全閉塞（CTO）市場レポート作成時に参照した一次情報および二次情報の一つです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 2次調査
  • 1次調査
    • 仮説の策定
    • マクロ経済要因分析
    • ファンデーション数値の開発
    • データの三角測量
    • 国レベルのデータ

第4章 慢性完全閉塞（CTO）市場情勢

  • 北米のPEST分析
  • 欧州のPEST分析
  • アジア太平洋のPEST分析
  • 中東・アフリカのPEST分析
  • 中南米のPEST分析

第5章 慢性完全閉塞（CTO）市場 - 主な市場力学

  • 慢性完全閉塞（CTO）市場 - 主な市場力学
  • 市場促進要因
    • 高齢化人口の増加
    • 心血管疾患の有病率の上昇
  • 市場抑制要因
    • 閉塞デバイスの高コスト
  • 市場機会
    • 市場プレイヤーの戦略的取り組み
  • 今後の動向
    • CTOデバイスの技術的進歩
  • 促進要因と抑制要因の影響

第6章 慢性完全閉塞（CTO）市場：世界市場分析

  • 慢性完全閉塞（CTO）市場の収益、2021-2031年
  • 慢性完全閉塞（CTO）市場の予測分析
  • 主要企業の市場ポジショニング

第7章 慢性完全閉塞（CTO）市場分析 - 機器別

  • ガイドワイヤー
  • マイクロカテーテル
  • クロスデバイス
  • リエントリーデバイス
  • その他

第8章 慢性完全閉塞（CTO）市場分析 - エンドユーザー別

  • 病院
  • 外来医療センター
  • その他

第9章 慢性完全閉塞（CTO）市場 - 地域別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他アジア太平洋
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • その他中東・アフリカ
  • 中南米
    • ブラジル
    • アルゼンチン
    • その他中南米

第10章 慢性完全閉塞（CTO）の世界市場に対するCOVID-19パンデミックの影響

  • 北米
  • 欧州
  • アジア太平洋
  • 中東・アフリカ
  • 中南米

第11章 慢性完全閉塞（CTO）市場 - 業界情勢

  • 慢性完全閉塞（CTO）市場における成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第12章 企業プロファイル

  • Asahi Intecc Co Ltd
  • Cordis Corp
  • Integer Holdings Corp
  • Boston Scientific Corp
  • Koninklijke Philips NV
  • Becton Dickinson and Co
  • Sound Bite Medical Solutions
  • Medtronic Plc
  • Terumo Corp
  • Abbott Laboratories

第13章 付録

図表

List Of Tables

  • Table 1. Chronic Total Occlusion Market Segmentation
  • Table 2. Chronic Total Occlusion Market - Revenue, 2021- 2024 (US$ Million)
  • Table 3. Chronic Total Occlusion Market - Revenue, 2025- 2031 (US$ Million)
  • Table 4. Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by Equipment
  • Table 5. Chronic Total Occlusion Market - Revenue, 2025 - 2031(US$ Million) - by Equipment
  • Table 6. Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by End User
  • Table 7. Chronic Total Occlusion Market - Revenue, 2025 - 2031(US$ Million) - by End User
  • Table 8. North America: Chronic Total Occlusion Market - Revenue, 2021 - 2024 (US$ Million) - by Equipment
  • Table 9. North America: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Equipment
  • Table 10. North America: Chronic Total Occlusion Market - Revenue, 2021 - 2024 (US$ Million) - by End User
  • Table 11. North America: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 12. North America: Chronic Total Occlusion Market - Revenue, 2021 - 2024 (US$ Million) - by Country
  • Table 13. North America: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Country
  • Table 14. United States: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by Equipment
  • Table 15. United States: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Equipment
  • Table 16. United States: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by End User
  • Table 17. United States: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 18. Canada: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by Equipment
  • Table 19. Canada: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Equipment
  • Table 20. Canada: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by End User
  • Table 21. Canada: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 22. Mexico: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by Equipment
  • Table 23. Mexico: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Equipment
  • Table 24. Mexico: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by End User
  • Table 25. Mexico: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 26. Europe: Chronic Total Occlusion Market - Revenue, 2021 - 2024 (US$ Million) - by Equipment
  • Table 27. Europe: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Equipment
  • Table 28. Europe: Chronic Total Occlusion Market - Revenue, 2021 - 2024 (US$ Million) - by End User
  • Table 29. Europe: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 30. Europe: Chronic Total Occlusion Market - Revenue, 2021 - 2024 (US$ Million) - by Country
  • Table 31. Europe: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Country
  • Table 32. Germany: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by Equipment
  • Table 33. Germany: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Equipment
  • Table 34. Germany: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by End User
  • Table 35. Germany: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 36. United Kingdom: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by Equipment
  • Table 37. United Kingdom: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Equipment
  • Table 38. United Kingdom: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by End User
  • Table 39. United Kingdom: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 40. France: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by Equipment
  • Table 41. France: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Equipment
  • Table 42. France: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by End User
  • Table 43. France: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 44. Spain: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by Equipment
  • Table 45. Spain: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Equipment
  • Table 46. Spain: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by End User
  • Table 47. Spain: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 48. Italy: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by Equipment
  • Table 49. Italy: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Equipment
  • Table 50. Italy: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by End User
  • Table 51. Italy: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 52. Rest of Europe: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by Equipment
  • Table 53. Rest of Europe: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Equipment
  • Table 54. Rest of Europe: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by End User
  • Table 55. Rest of Europe: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 56. Asia Pacific: Chronic Total Occlusion Market - Revenue, 2021 - 2024 (US$ Million) - by Equipment
  • Table 57. Asia Pacific: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Equipment
  • Table 58. Asia Pacific: Chronic Total Occlusion Market - Revenue, 2021 - 2024 (US$ Million) - by End User
  • Table 59. Asia Pacific: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 60. Asia Pacific: Chronic Total Occlusion Market - Revenue, 2021 - 2024 (US$ Million) - by Country
  • Table 61. Asia Pacific: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Country
  • Table 62. China: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by Equipment
  • Table 63. China: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Equipment
  • Table 64. China: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by End User
  • Table 65. China: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 66. Japan: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by Equipment
  • Table 67. Japan: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Equipment
  • Table 68. Japan: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by End User
  • Table 69. Japan: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 70. India: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by Equipment
  • Table 71. India: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Equipment
  • Table 72. India: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by End User
  • Table 73. India: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 74. Australia: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by Equipment
  • Table 75. Australia: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Equipment
  • Table 76. Australia: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by End User
  • Table 77. Australia: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 78. South Korea: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by Equipment
  • Table 79. South Korea: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Equipment
  • Table 80. South Korea: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by End User
  • Table 81. South Korea: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 82. Rest of APAC: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by Equipment
  • Table 83. Rest of APAC: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Equipment
  • Table 84. Rest of APAC: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by End User
  • Table 85. Rest of APAC: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 86. Middle East and Africa: Chronic Total Occlusion Market - Revenue, 2021 - 2024 (US$ Million) - by Equipment
  • Table 87. Middle East and Africa: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Equipment
  • Table 88. Middle East and Africa: Chronic Total Occlusion Market - Revenue, 2021 - 2024 (US$ Million) - by End User
  • Table 89. Middle East and Africa: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 90. Middle East and Africa: Chronic Total Occlusion Market - Revenue, 2021 - 2024 (US$ Million) - by Country
  • Table 91. Middle East and Africa: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Country
  • Table 92. Saudi Arabia: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by Equipment
  • Table 93. Saudi Arabia: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Equipment
  • Table 94. Saudi Arabia: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by End User
  • Table 95. Saudi Arabia: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 96. South Africa: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by Equipment
  • Table 97. South Africa: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Equipment
  • Table 98. South Africa: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by End User
  • Table 99. South Africa: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 100. United Arab Emirates: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by Equipment
  • Table 101. United Arab Emirates: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Equipment
  • Table 102. United Arab Emirates: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by End User
  • Table 103. United Arab Emirates: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 104. Rest of Middle East and Africa: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by Equipment
  • Table 105. Rest of Middle East and Africa: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Equipment
  • Table 106. Rest of Middle East and Africa: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by End User
  • Table 107. Rest of Middle East and Africa: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 108. South and Central America: Chronic Total Occlusion Market - Revenue, 2021 - 2024 (US$ Million) - by Equipment
  • Table 109. South and Central America: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Equipment
  • Table 110. South and Central America: Chronic Total Occlusion Market - Revenue, 2021 - 2024 (US$ Million) - by End User
  • Table 111. South and Central America: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 112. South and Central America: Chronic Total Occlusion Market - Revenue, 2021 - 2024 (US$ Million) - by Country
  • Table 113. South and Central America: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Country
  • Table 114. Brazil: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by Equipment
  • Table 115. Brazil: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Equipment
  • Table 116. Brazil: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by End User
  • Table 117. Brazil: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 118. Argentina: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by Equipment
  • Table 119. Argentina: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Equipment
  • Table 120. Argentina: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by End User
  • Table 121. Argentina: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 122. Rest of South and Central America: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by Equipment
  • Table 123. Rest of South and Central America: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by Equipment
  • Table 124. Rest of South and Central America: Chronic Total Occlusion Market - Revenue, 2021 -2024(US$ Million) - by End User
  • Table 125. Rest of South and Central America: Chronic Total Occlusion Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 126. Recent Organic Growth Strategies in the Chronic Total Occlusion Market
  • Table 127. Recent Inorganic Growth Strategies in the Chronic Total Occlusion Market
  • Table 128. Glossary of Terms

List Of Figures

  • Figure 1. Chronic Total Occlusion Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 5. Chronic Total Occlusion Market Revenue (US$ Million), 2021-2031
  • Figure 6. Market Positioning of Key Players in Global CTO Market
  • Figure 7. Chronic Total Occlusion Market Share (%) - by Equipment (2024 and 2031)
  • Figure 8. Guide Wires: Chronic Total Occlusion Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Micro Catheters: Chronic Total Occlusion Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Crossing Devices: Chronic Total Occlusion Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Re-Entry Devices: Chronic Total Occlusion Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Others: Chronic Total Occlusion Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Chronic Total Occlusion Market Share (%) - by End User (2024 and 2031)
  • Figure 14. Hospitals: Chronic Total Occlusion Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Ambulatory Care Centers: Chronic Total Occlusion Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Others: Chronic Total Occlusion Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Chronic Total Occlusion Market Breakdown by Region, 2024 and 2031 (%)
  • Figure 18. North America: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 19. North America: Chronic Total Occlusion Market Breakdown, by Equipment (2024 and 2031)
  • Figure 20. North America: Chronic Total Occlusion Market Breakdown, by End User (2024 and 2031)
  • Figure 21. North America: Chronic Total Occlusion Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 22. United States: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 23. Canada: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 24. Mexico: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 25. Europe: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 26. Europe: Chronic Total Occlusion Market Breakdown, by Equipment (2024 and 2031)
  • Figure 27. Europe: Chronic Total Occlusion Market Breakdown, by End User (2024 and 2031)
  • Figure 28. Europe: Chronic Total Occlusion Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 29. Germany: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 30. United Kingdom: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 31. France: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 32. Spain: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 33. Italy: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 34. Rest of Europe: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 35. Asia Pacific: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 36. Asia Pacific: Chronic Total Occlusion Market Breakdown, by Equipment (2024 and 2031)
  • Figure 37. Asia Pacific: Chronic Total Occlusion Market Breakdown, by End User (2024 and 2031)
  • Figure 38. Asia Pacific: Chronic Total Occlusion Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 39. China: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 40. Japan: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 41. India: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 42. Australia: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 43. South Korea: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 44. Rest of APAC: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 45. Middle East and Africa: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 46. Middle East and Africa: Chronic Total Occlusion Market Breakdown, by Equipment (2024 and 2031)
  • Figure 47. Middle East and Africa: Chronic Total Occlusion Market Breakdown, by End User (2024 and 2031)
  • Figure 48. Middle East and Africa: Chronic Total Occlusion Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 49. Saudi Arabia: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 50. South Africa: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 51. United Arab Emirates: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 52. Rest of Middle East and Africa: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 53. South and Central America: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 54. South and Central America: Chronic Total Occlusion Market Breakdown, by Equipment (2024 and 2031)
  • Figure 55. South and Central America: Chronic Total Occlusion Market Breakdown, by End User (2024 and 2031)
  • Figure 56. South and Central America: Chronic Total Occlusion Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 57. Brazil: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 58. Argentina: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 59. Rest of South and Central America: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 60. Growth Strategies in the Chronic Total Occlusion Market
目次
Product Code: TIPMD00002711

According to our new research study on "Chronic Total Occlusion Market Forecast to 2031 -Global Analysis - by Equipment, End User, and Geography," the market is anticipated to grow from US$ 2.44 billion in 2024 and is projected to reach US$ 4.22 billion by 2031; it is expected to register a CAGR of 8.2% during 2025-2031. increasing aging population and the rising prevalence of cardiovascular diseases are contributing to the growing chronic total occlusion market size. However, the high cost of occlusion devices hampers the chronic total occlusion market growth. Further, technological advancements in CTO devices is expected to bring in new chronic total occlusion market trends in the coming years.

In terms of revenue, North America dominated the market in 2024. It is estimated to dominate the global market during the forecast period. The US is the largest market for chronic total occlusion in the world.

The US chronic total occlusion market is growing with the rising incidence of CVD, especially Coronary Artery Disease (CAD), in the aging population. The American Heart Association's (AHA) 2023 Heart Disease and Stroke Statistics Update mentions that approximately 18.2 million adults in the country had CAD. The adoption of minimally invasive methods, including percutaneous coronary intervention (PCI), and the development of sophisticated CTO-specific devices are the major driving forces for market growth. Global leaders such as Medtronic, Boston Scientific, Abbott Laboratories, and Philips Healthcare dominate the US market with their innovative devices and technologies for CTO procedures. The strong healthcare infrastructure, reimbursement policies, and emphasis on enhancing patient outcomes fuel market growth. The growing number of specialized centers and well-trained cardiologists favor the application of CTO procedures. As per the Division of Occupational Employment and Wage Statistics, there were 15,190 employed cardiologists in the US as of 2023. In addition, growing consciousness about cardiovascular health and detection of CTO at an early stage fuel the demand for these interventions.

Chronic Total Occlusion Market Analysis

Strategic Initiatives by Market Players to Provide Market Opportunities in Future

Companies operating in the CTO market constantly focus on strategic developments such as product approvals, collaborations, funding, agreements, and new product launches, which help them improve their sales, increase their geographic reach, and reinforce their capacities to cater to a greater than existing customer base. A few strategic initiatives by key players operating in the CTO market are mentioned below.

In February 2022, Teleflex Incorporated announced that the U.S. Food and Drug Administration (FDA) granted expanded indications for its specialty catheters and coronary guidewires, specifically for use in chronic total occlusion percutaneous coronary interventions (CTO PCI).

In June 2024, MicroPort RotaPace's Intravascular Piezoelectric Guidewire System gained NMPA approval for entry into the special review procedures for innovative medical devices. This system was co-developed by a team led by Academician Junbo Ge from Zhongshan Hospital, Fudan University.

In February 2024, BIOTRONIK introduced the Micro Rx catheter, a novel rapid exchange microcatheter developed to easily enhance guidewire support during PCI. The Micro Rx catheter is the fourth IMDS product that BIOTRONIK has introduced to the US market, contributing to a strong portfolio of devices, which includes the NHancer Rx, TrapIT, and ReCross catheters.

In October 2022, the FDA-approved NovaCross line of microcatheters (NovaCross BTK for below-the-knee treatment, NovaCross Xtreme for chronic total occlusion treatment, and NovaCross CTO for chronic total occlusion treatment) was among the assets that Microbot Medical Inc. purchased from Nitiloop Ltd. The NovaCross devices are designed to make it easier to implant conventional and steerable guidewires intraluminally beyond stenotic lesions, including chronic complete occlusions, prior to percutaneous transluminal coronary angioplasty or stent intervention.

In April 2022, the FDA approved Transit Scientific's XO Cross Support Catheter Platform for coronary usage. The platform is intended to facilitate wire exchanges, guide and maintain a guidewire during access to the peripheral or coronary arteries, and serve as a conduit for the administration of diagnostic contrast agents or saline solutions.

In February 2022, the FDA approved an additional indication for Teleflex Incorporated's specialized catheters and coronary guidewires to be used in crossing chronic complete occlusion (CTO) during percutaneous coronary intervention (PCI).

In September 2023, Avinger, Inc. announced the full commercial launch of its Tigereye ST next-generation image-guided CTO crossing system. With the initiation of a full commercial launch, all current and prospective accounts can now order the Tigereye ST device.

Therefore, product launches, approvals, and collaborations are expected to create ample opportunities for the growth of the chronic complete occlusion (CTO) market in the coming years.

Chronic Total Occlusion Market Report Segmentation Analysis

Key segments that contributed to the derivation of the chronic total occlusion market analysis are equipment and end user.

Based on equipment, the chronic total occlusion market is segmented into guide wires, micro catheters, crossing devices, re-entry devices, and others. The guide wires segment held the largest share of the market in 2024.

In terms of end user, the chronic total occlusion market is categorized into hospitals, ambulatory care centers, and others. The hospitals segment dominated the market in 2024.

Chronic Total Occlusion Market: Competitive Landscape and Key Developments

Asahi Intecc Co Ltd, Cordis Corp, Integer Holdings Corp, Boston Scientific Corp, Becton Dickinson and Co, SoundBite Medical Solutions, Medtronic Plc, Terumo Corp, Abbott, and Koninklijke Philips NV are among the key companies operating in the chronic total occlusion market.

US Census Bureau, World Health Organization (WHO), British Heart Foundation, French National Institute for Demographic Studies, National Institute of Statistics (NIS), National Library of Medicine, National Crime Records Bureau (NCRB), and National Center for Biotechnology Information are among the primary and secondary sources referred to while preparing the chronic total occlusion market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Chronic Total Occlusion Market Landscape

  • 4.1 Overview
  • 4.2 North America PEST Analysis
  • 4.3 Europe PEST Analysis
  • 4.4 Asia Pacific PEST Analysis
  • 4.5 Middle-East and Africa PEST Analysis
  • 4.6 South and Central America PEST Analysis

5. Chronic Total Occlusion Market - Key Market Dynamics

  • 5.1 Chronic Total Occlusion Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Aging Population
    • 5.2.2 Rising Prevalence of Cardiovascular Diseases
  • 5.3 Market Restraints
    • 5.3.1 High Cost of Occlusion Devices
  • 5.4 Market Opportunities
    • 5.4.1 Strategic Initiatives by Market Players
  • 5.5 Future Trends
    • 5.5.1 Technological Advancements in CTO Devices
  • 5.6 Impact of Drivers and Restraints:

6. Chronic Total Occlusion Market - Global Market Analysis

  • 6.1 Chronic Total Occlusion Market Revenue (US$ Million), 2021-2031
  • 6.2 Chronic Total Occlusion Market Forecast Analysis
  • 6.3 Market Positioning of Key Players

7. Chronic Total Occlusion Market Analysis - by Equipment

  • 7.1 Guide Wires
    • 7.1.1 Overview
    • 7.1.2 Guide Wires: Chronic Total Occlusion Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Micro Catheters
    • 7.2.1 Overview
    • 7.2.2 Micro Catheters: Chronic Total Occlusion Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Crossing Devices
    • 7.3.1 Overview
    • 7.3.2 Crossing Devices: Chronic Total Occlusion Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Re-Entry Devices
    • 7.4.1 Overview
    • 7.4.2 Re-Entry Devices: Chronic Total Occlusion Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Chronic Total Occlusion Market - Revenue and Forecast to 2031 (US$ Million)

8. Chronic Total Occlusion Market Analysis - by End User

  • 8.1 Hospitals
    • 8.1.1 Overview
    • 8.1.2 Hospitals: Chronic Total Occlusion Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Ambulatory Care Centers
    • 8.2.1 Overview
    • 8.2.2 Ambulatory Care Centers: Chronic Total Occlusion Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Others
    • 8.3.1 Overview
    • 8.3.2 Others: Chronic Total Occlusion Market - Revenue and Forecast to 2031 (US$ Million)

9. Chronic Total Occlusion Market - Geographical Analysis

  • 9.1 Overview
  • 9.2 North America
    • 9.2.1 North America: Chronic Total Occlusion Market Overview
    • 9.2.2 North America: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
    • 9.2.3 North America: Chronic Total Occlusion Market Breakdown, by Equipment
      • 9.2.3.1 North America: Chronic Total Occlusion Market- Revenue and Forecast Analysis - by Equipment
    • 9.2.4 North America: Chronic Total Occlusion Market Breakdown, by End User
      • 9.2.4.1 North America: Chronic Total Occlusion Market- Revenue and Forecast Analysis - by End User
    • 9.2.5 North America: Chronic Total Occlusion Market - Revenue and Forecast Analysis - by Country
      • 9.2.5.1 North America: Chronic Total Occlusion Market - Revenue and Forecast Analysis - by Country
      • 9.2.5.2 United States: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
        • 9.2.5.2.1 United States: Chronic Total Occlusion Market Breakdown, by Equipment
        • 9.2.5.2.2 United States: Chronic Total Occlusion Market Breakdown, by End User
      • 9.2.5.3 Canada: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
        • 9.2.5.3.1 Canada: Chronic Total Occlusion Market Breakdown, by Equipment
        • 9.2.5.3.2 Canada: Chronic Total Occlusion Market Breakdown, by End User
      • 9.2.5.4 Mexico: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
        • 9.2.5.4.1 Mexico: Chronic Total Occlusion Market Breakdown, by Equipment
        • 9.2.5.4.2 Mexico: Chronic Total Occlusion Market Breakdown, by End User
  • 9.3 Europe
    • 9.3.1 Europe Chronic Total Occlusion Market Overview
    • 9.3.2 Europe: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
    • 9.3.3 Europe: Chronic Total Occlusion Market Breakdown, by Equipment
      • 9.3.3.1 Europe: Chronic Total Occlusion Market- Revenue and Forecast Analysis - by Equipment
    • 9.3.4 Europe: Chronic Total Occlusion Market Breakdown, by End User
      • 9.3.4.1 Europe: Chronic Total Occlusion Market- Revenue and Forecast Analysis - by End User
    • 9.3.5 Europe: Chronic Total Occlusion Market - Revenue and Forecast Analysis - by Country
      • 9.3.5.1 Europe: Chronic Total Occlusion Market - Revenue and Forecast Analysis - by Country
      • 9.3.5.2 Germany: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
        • 9.3.5.2.1 Germany: Chronic Total Occlusion Market Breakdown, by Equipment
        • 9.3.5.2.2 Germany: Chronic Total Occlusion Market Breakdown, by End User
      • 9.3.5.3 United Kingdom: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
        • 9.3.5.3.1 United Kingdom: Chronic Total Occlusion Market Breakdown, by Equipment
        • 9.3.5.3.2 United Kingdom: Chronic Total Occlusion Market Breakdown, by End User
      • 9.3.5.4 France: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
        • 9.3.5.4.1 France: Chronic Total Occlusion Market Breakdown, by Equipment
        • 9.3.5.4.2 France: Chronic Total Occlusion Market Breakdown, by End User
      • 9.3.5.5 Spain: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
        • 9.3.5.5.1 Spain: Chronic Total Occlusion Market Breakdown, by Equipment
        • 9.3.5.5.2 Spain: Chronic Total Occlusion Market Breakdown, by End User
      • 9.3.5.6 Italy: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
        • 9.3.5.6.1 Italy: Chronic Total Occlusion Market Breakdown, by Equipment
        • 9.3.5.6.2 Italy: Chronic Total Occlusion Market Breakdown, by End User
      • 9.3.5.7 Rest of Europe: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
        • 9.3.5.7.1 Rest of Europe: Chronic Total Occlusion Market Breakdown, by Equipment
        • 9.3.5.7.2 Rest of Europe: Chronic Total Occlusion Market Breakdown, by End User
  • 9.4 Asia Pacific
    • 9.4.1 Asia Pacific Chronic Total Occlusion Market Overview
    • 9.4.2 Asia Pacific: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
    • 9.4.3 Asia Pacific: Chronic Total Occlusion Market Breakdown, by Equipment
      • 9.4.3.1 Asia Pacific: Chronic Total Occlusion Market- Revenue and Forecast Analysis - by Equipment
    • 9.4.4 Asia Pacific: Chronic Total Occlusion Market Breakdown, by End User
      • 9.4.4.1 Asia Pacific: Chronic Total Occlusion Market- Revenue and Forecast Analysis - by End User
    • 9.4.5 Asia Pacific: Chronic Total Occlusion Market - Revenue and Forecast Analysis - by Country
      • 9.4.5.1 Asia Pacific: Chronic Total Occlusion Market - Revenue and Forecast Analysis - by Country
      • 9.4.5.2 China: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
        • 9.4.5.2.1 China: Chronic Total Occlusion Market Breakdown, by Equipment
        • 9.4.5.2.2 China: Chronic Total Occlusion Market Breakdown, by End User
      • 9.4.5.3 Japan: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
        • 9.4.5.3.1 Japan: Chronic Total Occlusion Market Breakdown, by Equipment
        • 9.4.5.3.2 Japan: Chronic Total Occlusion Market Breakdown, by End User
      • 9.4.5.4 India: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
        • 9.4.5.4.1 India: Chronic Total Occlusion Market Breakdown, by Equipment
        • 9.4.5.4.2 India: Chronic Total Occlusion Market Breakdown, by End User
      • 9.4.5.5 Australia: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
        • 9.4.5.5.1 Australia: Chronic Total Occlusion Market Breakdown, by Equipment
        • 9.4.5.5.2 Australia: Chronic Total Occlusion Market Breakdown, by End User
      • 9.4.5.6 South Korea: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
        • 9.4.5.6.1 South Korea: Chronic Total Occlusion Market Breakdown, by Equipment
        • 9.4.5.6.2 South Korea: Chronic Total Occlusion Market Breakdown, by End User
      • 9.4.5.7 Rest of APAC: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
        • 9.4.5.7.1 Rest of APAC: Chronic Total Occlusion Market Breakdown, by Equipment
        • 9.4.5.7.2 Rest of APAC: Chronic Total Occlusion Market Breakdown, by End User
  • 9.5 Middle East and Africa
    • 9.5.1 Middle East and Africa Chronic Total Occlusion Market Overview
    • 9.5.2 Middle East and Africa: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
    • 9.5.3 Middle East and Africa: Chronic Total Occlusion Market Breakdown, by Equipment
      • 9.5.3.1 Middle East and Africa: Chronic Total Occlusion Market- Revenue and Forecast Analysis - by Equipment
    • 9.5.4 Middle East and Africa: Chronic Total Occlusion Market Breakdown, by End User
      • 9.5.4.1 Middle East and Africa: Chronic Total Occlusion Market- Revenue and Forecast Analysis - by End User
    • 9.5.5 Middle East and Africa: Chronic Total Occlusion Market - Revenue and Forecast Analysis - by Country
      • 9.5.5.1 Middle East and Africa: Chronic Total Occlusion Market - Revenue and Forecast Analysis - by Country
      • 9.5.5.2 Saudi Arabia: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
        • 9.5.5.2.1 Saudi Arabia: Chronic Total Occlusion Market Breakdown, by Equipment
        • 9.5.5.2.2 Saudi Arabia: Chronic Total Occlusion Market Breakdown, by End User
      • 9.5.5.3 South Africa: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
        • 9.5.5.3.1 South Africa: Chronic Total Occlusion Market Breakdown, by Equipment
        • 9.5.5.3.2 South Africa: Chronic Total Occlusion Market Breakdown, by End User
      • 9.5.5.4 United Arab Emirates: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
        • 9.5.5.4.1 United Arab Emirates: Chronic Total Occlusion Market Breakdown, by Equipment
        • 9.5.5.4.2 United Arab Emirates: Chronic Total Occlusion Market Breakdown, by End User
      • 9.5.5.5 Rest of Middle East and Africa: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
        • 9.5.5.5.1 Rest of Middle East and Africa: Chronic Total Occlusion Market Breakdown, by Equipment
        • 9.5.5.5.2 Rest of Middle East and Africa: Chronic Total Occlusion Market Breakdown, by End User
  • 9.6 South and Central America
    • 9.6.1 South and Central America Chronic Total Occlusion Market Overview
    • 9.6.2 South and Central America: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
    • 9.6.3 South and Central America: Chronic Total Occlusion Market Breakdown, by Equipment
      • 9.6.3.1 South and Central America: Chronic Total Occlusion Market- Revenue and Forecast Analysis - by Equipment
    • 9.6.4 South and Central America: Chronic Total Occlusion Market Breakdown, by End User
      • 9.6.4.1 South and Central America: Chronic Total Occlusion Market- Revenue and Forecast Analysis - by End User
    • 9.6.5 South and Central America: Chronic Total Occlusion Market - Revenue and Forecast Analysis - by Country
      • 9.6.5.1 South and Central America: Chronic Total Occlusion Market - Revenue and Forecast Analysis - by Country
      • 9.6.5.2 Brazil: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
        • 9.6.5.2.1 Brazil: Chronic Total Occlusion Market Breakdown, by Equipment
        • 9.6.5.2.2 Brazil: Chronic Total Occlusion Market Breakdown, by End User
      • 9.6.5.3 Argentina: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
        • 9.6.5.3.1 Argentina: Chronic Total Occlusion Market Breakdown, by Equipment
        • 9.6.5.3.2 Argentina: Chronic Total Occlusion Market Breakdown, by End User
      • 9.6.5.4 Rest of South and Central America: Chronic Total Occlusion Market - Revenue, 2021 - 2031 (US$ Million)
        • 9.6.5.4.1 Rest of South and Central America: Chronic Total Occlusion Market Breakdown, by Equipment
        • 9.6.5.4.2 Rest of South and Central America: Chronic Total Occlusion Market Breakdown, by End User

10. Impact of COVID-19 Pandemic on Global Chronic Total Occlusion Market

  • 10.1 North America
  • 10.2 Europe
  • 10.3 Asia-Pacific
  • 10.4 Middle East and Africa
  • 10.5 South and Central America

11. Chronic Total Occlusion Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Chronic Total Occlusion Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Asahi Intecc Co Ltd
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Cordis Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Integer Holdings Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Boston Scientific Corp
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Koninklijke Philips NV
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Becton Dickinson and Co
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Sound Bite Medical Solutions
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Medtronic Plc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Terumo Corp
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Abbott Laboratories
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms